CN106166272A - A kind of Chinese medicine composition treating necrosis - Google Patents
A kind of Chinese medicine composition treating necrosis Download PDFInfo
- Publication number
- CN106166272A CN106166272A CN201610725497.2A CN201610725497A CN106166272A CN 106166272 A CN106166272 A CN 106166272A CN 201610725497 A CN201610725497 A CN 201610725497A CN 106166272 A CN106166272 A CN 106166272A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- medicine
- radix
- eupolyphaga
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 230000017074 necrotic cell death Effects 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 18
- 241001489978 Eupolyphaga Species 0.000 claims abstract description 15
- 241000237903 Hirudo Species 0.000 claims abstract description 15
- 241000221377 Auricularia Species 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 5
- 238000009835 boiling Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 230000003203 everyday effect Effects 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 206010028851 Necrosis Diseases 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 206010047115 Vasculitis Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 210000001699 lower leg Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010017711 Gangrene Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000487918 Acacia argyrodendron Species 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000011222 chang cao shi Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000000453 second toe Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of Chinese medicine composition treating necrosis, it is characterized in that, including endo-medicine and external used medicine, wherein said endo-medicine is made up of the component of following weight: eupolyphaga 69 grams, Rhizoma Wenyujin Concisum 39 grams, Hirudo 69 grams, Auricularia 25 30 grams, Radix Paeoniae Rubra 69 grams, Herba Asari 3 grams, Radix Notoginseng powder 3 grams, Radix Cyathulae 9 15 grams；Described external used medicine is made up of the component of following weight: eupolyphaga 15 25 grams, Hirudo 20 30 grams, Auricularia 25 30 grams, Herba Asari 12 15 grams, Radix Notoginseng powder 69 grams, the Fructus Crotonis 23 that deoils, Flos Lonicerae 20 25 grams.The present invention uses Chinese herbal medicine formula, material to be easy to get, and preparation method is simple, oral administration and externally, and therapeutic effect is good, and price is low, instant effect, and curative effect is reliable, with system with without obvious adverse reaction and side effect.
Description
Technical field
The present invention relates to technical field of Chinese medicine, be specifically related to a kind of Chinese medicine composition treating necrosis.
Background technology
Necrosis one disease is thromboangiitis obliterans alleged in modern medicine, and primary disease is thought an effective reinforcement by motherland's medical science
Arteries and veins is got involved, the chronic disease that apotelus necrosis comes off, and is also the scope of middle gangrene of finger or toe.Its cause of disease all feelings will internal injury, temper is not strong, Liver and kidney
Not enough, cold-damp is attacked, wound stimulates so that it is venation numbness plug, QI and blood being obstructed, extremity are that the cold main spasm in end of all sun stagnates, acra
Easily by numbness plug, failing preventing and treating time long, QI and blood is retarded by silt then ZIJING, podomere can not QI and blood warm moisten foster.Then feel cold numb, pale, step
Carry out inconvenience, therefore just refer to joint necrosis.The traditional Chinese medical science is point cold-dampness type, blood stasis type, heat-toxin type, QIXUELIANGXU type, renal deficiency type, typing in dialectical
Treat.According to characteristics of incidence, use to nourish blood and seek, the drug regimen of relaxing muscles and tendons and activating QI and blood in the collateral, expelling wind and clearing away heat.Prove through long-term practice
Effective herbal composite is provided for treatment necrosis.
Summary of the invention
The technical problem to be solved is to provide a kind of combination simple, the Chinese drug-treated group of eutherapeutic treatment necrosis
Compound.
The technical problem to be solved realizes by the following technical solutions:
A kind of Chinese medicine composition treating necrosis, including endo-medicine and external used medicine, wherein said endo-medicine be by
The component of following weight is made: eupolyphaga 6-9 gram, Rhizoma Wenyujin Concisum 3-9 gram, Hirudo 6-9 gram, Auricularia 25-30 gram, Radix Paeoniae Rubra 6-9 gram, thin
Pungent 3 grams, Radix Notoginseng powder 3 grams, Radix Cyathulae 9-15 gram；The preparation method of above-mentioned endo-medicine is: by eupolyphaga, Rhizoma Wenyujin Concisum, Hirudo, black wood
Ear, Radix Paeoniae Rubra, Herba Asari and Radix Cyathulae added water no in being placed in marmite powder, with slow fire boiling after soaking 60-90 minute, after boiling again
Continue and boil 15 minutes, liquid 200 milliliters of every time boiling medicine, put into Radix Notoginseng powder and stir evenly, every day 2 times, for oral administration；
Described external used medicine is made up of the component of following weight: eupolyphaga 15-25 gram, Hirudo 20-30 gram, Auricularia 25-
30 grams, Herba Asari 12-15 gram, Radix Notoginseng powder 6-9 gram, deoil Fructus Crotonis 2-3 grain (broken), Flos Lonicerae 20-25 gram；The system of above-mentioned external used medicine
Preparation Method is: said medicine being placed in marmite and add water in right amount, decoct about 12 minutes, filtrate 1200-1500 milliliter, temperature is fitted
Preferably, pour foot bath in basin into, soak 12 minutes every time, the most once.
Effect: promoting blood circulation to remove blood stasis, the logical pain relieving of temperature, expand blood vessel, environment spasm.
Study mechanism: eupolyphaga breaks congestion abdominal mass；Hirudo blood circulation promoting and blood stasis dispelling thrombolytic, releases arteriospasm；Auricularia contains abundant
Protein, trace element, nicotinic acid, injection Vitamin B_6, thrombolytic blood sugar lowering, expand blood vessel, nutrition blood is sought, and antioxidation improves Tissue Blood
Confession, repairing ulcer and slough；It is stagnant that Radix Paeoniae Rubra expands the logical heap soil or fertilizer over and around the roots of blood vessel；Pseudo-ginseng blood-circulation-invigovating, analgesic hemostatic；Rhizoma Wenyujin Concisum, Herba Asari temperature pain relieving；River
Radix Achyranthis Bidentatae the meridian dredging, draws the through sick institute of all medicines.
The present composition has carried out substantial amounts of animal acute toxicity test, long-term toxicity test for animals and treatment disease
A large amount of clinical trials, the use link that this medicine puts into treatment disease provides science and objective foundation.Its test method
As follows with result of the test:
(1) medicinal liquid for oral administration preparing the present invention carries out animal acute toxicity test:
Medicine: the crude drug used in the present invention is commercially available from common Chinese shop, its specification meets country's Chinese crude drug mark
Accurate.
Experimental animal: white mice, body weight randomly chooses in about 50g, male and female, market buys.
Method and result: take white mice 10, hungry about 20 hours, fill for 5 times by every every natural gift and feed 50ml, feed continuously
One week, observing 10 days, mice is movable normal, non-toxic reaction, without dead.Show that oral liquid is without acute toxicity, clinical application agent
Amount safety.
(2) medicinal liquid for oral administration preparing the present invention carries out long-term toxicity test for animals:
Experimental animal: rat, body weight randomly chooses in 120-130g, male and female, market buys.
Method and result: take rat 20, be divided into 2 groups, often group 10, and wherein the 1st group as administration group, every by every
Filling for they 2 times and feed, each 5-10ml, the 2nd group of diet as a control group, once a day, fills continuously and feeds 90 days, survey body
Weight, is administered latter 24 hours sacrificed by decapitation in last, surveys blood, routine urinalysis, liver function, renal function, cores, the internal organs such as kidney, sees
Examining the change of tissue morphology, observe the effect of dosage, observe diet, movable change, experiment proves administration group and matched group ratio
Relatively without notable change, equal non-toxic reaction, it is a kind of safe drugs.
The invention has the beneficial effects as follows: the present invention uses Chinese herbal medicine formula, material to be easy to get, preparation method is simple, outside taking orally
With, therapeutic effect is good, and price is low, instant effect, and curative effect is reliable, with system with without obvious adverse reaction and side effect.
Detailed description of the invention
For the technological means making the present invention realize, creation characteristic, reach purpose and be easy to understand with effect, below knot
Close specific embodiment, the present invention is expanded on further.
Embodiment 1
A kind of Chinese medicine composition treating necrosis, including endo-medicine and external used medicine, wherein said endo-medicine be by
The component of following weight is made: eupolyphaga 6 grams, Rhizoma Wenyujin Concisum 3 grams, Hirudo 6 grams, Auricularia 25 grams, Radix Paeoniae Rubra 6 grams, Herba Asari 3 grams, Radix Notoginseng
3 grams of powder, Radix Cyathulae 9 grams；The preparation method of above-mentioned endo-medicine is: by eupolyphaga, Rhizoma Wenyujin Concisum, Hirudo, Auricularia, Radix Paeoniae Rubra, Herba Asari
Add water in being placed in marmite with Radix Cyathulae not powder, with slow fire boiling after soaking 60-90 minute, renew after boiling and boil 15 minutes,
Boil medicine liquid 200 milliliters every time, put into Radix Notoginseng powder and stir evenly, every day 2 times, for oral administration；
Described external used medicine is made up of the component of following weight: eupolyphaga 15 grams, Hirudo 20 grams, Auricularia 25 grams, Herba Asari
12 grams, Radix Notoginseng powder 6 grams, deoil Fructus Crotonis 2 (broken), Flos Lonicerae 20 grams；The preparation method of above-mentioned external used medicine is: by said medicine
It is placed in marmite and adds water in right amount, decoct about 12 minutes, filtrate 1200-1500 milliliter, proper temperature, pour foot bath in basin into, every time
Soak 12 minutes, the most once.
Embodiment 2
A kind of Chinese medicine composition treating necrosis, including endo-medicine and external used medicine, wherein said endo-medicine be by
The component of following weight is made: eupolyphaga 9 grams, Rhizoma Wenyujin Concisum 9 grams, Hirudo 9 grams, Auricularia 30 grams, Radix Paeoniae Rubra 9 grams, Herba Asari 3 grams, Radix Notoginseng
3 grams of powder, Radix Cyathulae 15 grams；The preparation method of above-mentioned endo-medicine is: by eupolyphaga, Rhizoma Wenyujin Concisum, Hirudo, Auricularia, Radix Paeoniae Rubra, Herba Asari
Add water in being placed in marmite with Radix Cyathulae not powder, with slow fire boiling after soaking 60-90 minute, renew after boiling and boil 15 minutes,
Boil medicine liquid 200 milliliters every time, put into Radix Notoginseng powder and stir evenly, every day 2 times, for oral administration；
Described external used medicine is made up of the component of following weight: eupolyphaga 25 grams, Hirudo 30 grams, Auricularia 30 grams, Herba Asari
15 grams, Radix Notoginseng powder 9 grams, deoil Fructus Crotonis 3 (broken), Flos Lonicerae 25 grams；The preparation method of above-mentioned external used medicine is: by said medicine
It is placed in marmite and adds water in right amount, decoct about 12 minutes, filtrate 1200-1500 milliliter, proper temperature, pour foot bath in basin into, every time
Soak 12 minutes, the most once.
Model case:
1. Huang Shi, female, 74 years old, people from Dancheng, Henan, right crus of diaphragm was numb, and intermittent slope row, rear calcaneodynia, purple is the most shrivelled, to Zhengzhou
Provincial hospital is diagnosed as vasculitis through Doppler, with the recovery from illness in nearly 3 months of the embodiment of the present invention 1 Drug therapy.
2. Lee so-and-so, man, 35 years old, people from Jieshou City, Anhui, there is cold extremities in right crus of diaphragm, pale, tranquillization ache, night is many very, rear three
Toe occurs dark violet.It is diagnosed as vasculitis, with the recovery from illness in nearly 4 months of the embodiment of the present invention 1 Drug therapy to hospital general of Nanjing Military Command.
3. temperature so-and-so, man, 83 years old, people from Jieshou City, Anhui, right crus of diaphragm performance numbness, Shi Leng, intermittent slope row, continue tranquillization
Pain, night, weight, dark violet, and slight gangrene occurs in the second toe, and Medical University Of Anhui is diagnosed as vasculitis, by the embodiment of the present invention 2
Drug therapy recovery from illness in nearly 3 months.
The ultimate principle of the present invention and principal character and advantages of the present invention have more than been shown and described.The technology of the industry
Personnel, it should be appreciated that the present invention is not restricted to the described embodiments, simply illustrating this described in above-described embodiment and description
The principle of invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, and these become
Change and improvement both falls within scope of the claimed invention.Claimed scope by appending claims and
Equivalent defines.
Claims (3)
1. the Chinese medicine composition treating necrosis, it is characterised in that include endo-medicine and external used medicine, wherein said for oral administration
Medicine is made up of the component of following weight: eupolyphaga 6-9 gram, Rhizoma Wenyujin Concisum 3-9 gram, Hirudo 6-9 gram, Auricularia 25-30 gram, Radix Paeoniae Rubra
6-9 gram, Herba Asari 3 grams, Radix Notoginseng powder 3 grams, Radix Cyathulae 9-15 gram；
Described external used medicine is made up of the component of following weight: eupolyphaga 15-25 gram, Hirudo 20-30 gram, Auricularia 25-30 gram,
Herba Asari 12-15 gram, Radix Notoginseng powder 6-9 gram, deoil Fructus Crotonis 2-3 grain, Flos Lonicerae 20-25 gram.
A kind of Chinese medicine composition treating necrosis the most according to claim 1, it is characterised in that the system of above-mentioned endo-medicine
Preparation Method is: added water in eupolyphaga, Rhizoma Wenyujin Concisum, Hirudo, Auricularia, Radix Paeoniae Rubra, Herba Asari and Radix Cyathulae are placed in marmite no powder, leaching
With slow fire boiling after steeping 60-90 minute, renew after boiling and boil 15 minutes, liquid 200 milliliters of every time boiling medicine, put into Radix Notoginseng powder and stir evenly,
Every day 2 times, for oral administration.
A kind of Chinese medicine composition treating necrosis the most according to claim 1, it is characterised in that the system of above-mentioned external used medicine
Preparation Method is: said medicine is placed in marmite and adds water in right amount, decoct 12 minutes, filtrate 1200-1500 milliliter, proper temperature, falls
Foot bath in engagement, soaks 12 minutes every time, the most once.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610725497.2A CN106166272A (en) | 2016-08-25 | 2016-08-25 | A kind of Chinese medicine composition treating necrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610725497.2A CN106166272A (en) | 2016-08-25 | 2016-08-25 | A kind of Chinese medicine composition treating necrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106166272A true CN106166272A (en) | 2016-11-30 |
Family
ID=57376010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610725497.2A Pending CN106166272A (en) | 2016-08-25 | 2016-08-25 | A kind of Chinese medicine composition treating necrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106166272A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040058983A1 (en) * | 2000-08-18 | 2004-03-25 | Heikki Vuorela | Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| CN103585410A (en) * | 2013-10-18 | 2014-02-19 | 尹静 | Traditional Chinese medicine composition for treating angitis |
| CN104027775A (en) * | 2014-01-15 | 2014-09-10 | 解程 | Traditional Chinese medicine for treating thromboangiitis obliterans |
-
2016
- 2016-08-25 CN CN201610725497.2A patent/CN106166272A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040058983A1 (en) * | 2000-08-18 | 2004-03-25 | Heikki Vuorela | Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| CN103585410A (en) * | 2013-10-18 | 2014-02-19 | 尹静 | Traditional Chinese medicine composition for treating angitis |
| CN104027775A (en) * | 2014-01-15 | 2014-09-10 | 解程 | Traditional Chinese medicine for treating thromboangiitis obliterans |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105535694A (en) | Traditional Chinese medicine composition for treating hyperuricemia | |
| CN102688420B (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN101301354B (en) | Externally used medicinal liquor for treating psoriasis | |
| CN100522226C (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN104825619A (en) | Medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102697963B (en) | Traditional Chinese medicine composition for curing Raynaud's disease | |
| CN104069355A (en) | Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
| CN103585597B (en) | A kind of for alleviating because renal calculus causes the Chinese medicine composition had an intense pain | |
| CN106166272A (en) | A kind of Chinese medicine composition treating necrosis | |
| CN103721219A (en) | Traditional Chinese medicine composition for treating chronic gastropathy | |
| CN105944017A (en) | Traditional Chinese medicine composition for treating cancer and preparation method thereof | |
| CN104800302A (en) | Externally applied plaster for treating thromboangiitis obliterans and preparation method | |
| CN101401865A (en) | Chinese medicine composition for curing gout | |
| CN100363037C (en) | Medicine for treating rheumarthritis and traumatic injury pain and its prpen | |
| CN100418572C (en) | Oral Chinese medicine preparation for treating liver and gall bladder diseases | |
| CN103432418B (en) | Chinese medicine composition of a kind of gout pain relieving and its production and use | |
| CN106860652A (en) | A kind of decoction medicine for treating eczema and preparation method thereof | |
| CN106943476A (en) | It is a kind of to be used to treat decoction medicine of eczema and preparation method thereof | |
| CN106421514A (en) | Traditional Chinese medicine for treating arthralgia | |
| CN106421125A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN101628061A (en) | Medicine for treating urticaria | |
| CN103656347A (en) | Traditional Chinese medicine composition for treating cutaneous pruritus caused by eczema and preparation method thereof | |
| CN104587071A (en) | Traditional Chinese medicament for treating infantile blood-heat allergic purpura | |
| CN105267639A (en) | Pharmaceutical preparation used for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161130 |
|
| RJ01 | Rejection of invention patent application after publication |